Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. With Heidi Overton out, who’s gonna lead the FDA? We should endeavor a guess, March Madness-style. STAT Madness, regulatory edition. Merck enlists Isomorphic for mystery target Merck already has an oncology target it considers strategically important — and a trove of wet lab data from its own work on it. Now, STAT’s Katherine MacPhail writes exclusively, it’s bringing in Isomorphic Labs to see whether the DeepMind spinoff’s AI models can use those data to find promising small molecules faster. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe
STAT+: Lawmakers want U.S. biotech to outcompete China
Full Article
Original Source
Read the full article at Statnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.